290 related articles for article (PubMed ID: 28871199)
1. Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide.
Roeckel LA; Utard V; Reiss D; Mouheiche J; Maurin H; Robé A; Audouard E; Wood JN; Goumon Y; Simonin F; Gaveriaux-Ruff C
Sci Rep; 2017 Sep; 7(1):10406. PubMed ID: 28871199
[TBL] [Abstract][Full Text] [Related]
2. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
3. Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice.
Reiss D; Maduna T; Maurin H; Audouard E; Gaveriaux-Ruff C
J Neurosci Res; 2022 Jan; 100(1):203-219. PubMed ID: 32253777
[TBL] [Abstract][Full Text] [Related]
4. Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.
Corder G; Tawfik VL; Wang D; Sypek EI; Low SA; Dickinson JR; Sotoudeh C; Clark JD; Barres BA; Bohlen CJ; Scherrer G
Nat Med; 2017 Feb; 23(2):164-173. PubMed ID: 28092666
[TBL] [Abstract][Full Text] [Related]
5. Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia.
Oladosu FA; Conrad MS; O'Buckley SC; Rashid NU; Slade GD; Nackley AG
PLoS One; 2015; 10(8):e0135711. PubMed ID: 26270813
[TBL] [Abstract][Full Text] [Related]
6. Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide.
Swartjes M; Mooren RA; Waxman AR; Arout C; van de Wetering K; den Hartigh J; Beijnen JH; Kest B; Dahan A
Mol Med; 2012 Dec; 18(1):1320-6. PubMed ID: 23001479
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
[TBL] [Abstract][Full Text] [Related]
8. Genetic dissociation of morphine analgesia from hyperalgesia in mice.
Marrone GF; Le Rouzic V; Varadi A; Xu J; Rajadhyaksha AM; Majumdar S; Pan YX; Pasternak GW
Psychopharmacology (Berl); 2017 Jun; 234(12):1891-1900. PubMed ID: 28343361
[TBL] [Abstract][Full Text] [Related]
9. Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae.
Grace PM; Ramos KM; Rodgers KM; Wang X; Hutchinson MR; Lewis MT; Morgan KN; Kroll JL; Taylor FR; Strand KA; Zhang Y; Berkelhammer D; Huey MG; Greene LI; Cochran TA; Yin H; Barth DS; Johnson KW; Rice KC; Maier SF; Watkins LR
Neuroscience; 2014 Nov; 280():299-317. PubMed ID: 25241065
[TBL] [Abstract][Full Text] [Related]
10. Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling.
Due MR; Piekarz AD; Wilson N; Feldman P; Ripsch MS; Chavez S; Yin H; Khanna R; White FA
J Neuroinflammation; 2012 Aug; 9():200. PubMed ID: 22898544
[TBL] [Abstract][Full Text] [Related]
11. C-Fos activation in the periaqueductal gray following acute morphine-3β-D-glucuronide or morphine administration.
Arout CA; Caldwell M; McCloskey DP; Kest B
Physiol Behav; 2014 May; 130():28-33. PubMed ID: 24631297
[TBL] [Abstract][Full Text] [Related]
12. A murine model of opioid-induced hyperalgesia.
Li X; Angst MS; Clark JD
Brain Res Mol Brain Res; 2001 Jan; 86(1-2):56-62. PubMed ID: 11165371
[TBL] [Abstract][Full Text] [Related]
13. Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice.
Romberg R; Sarton E; Teppema L; Matthes HW; Kieffer BL; Dahan A
Br J Anaesth; 2003 Dec; 91(6):862-70. PubMed ID: 14633759
[TBL] [Abstract][Full Text] [Related]
14. Morphine-3-glucuronide causes antinociceptive cross-tolerance to morphine and increases spinal substance P expression.
Blomqvist KJ; Viisanen H; Ahlström FHG; Jokinen V; Sidorova YA; Suleymanova I; Rauhala PV; Kalso EA; Lilius TO
Eur J Pharmacol; 2020 May; 875():173021. PubMed ID: 32112778
[TBL] [Abstract][Full Text] [Related]
15. Opioid-induced hyperalgesia: Cellular and molecular mechanisms.
Roeckel LA; Le Coz GM; Gavériaux-Ruff C; Simonin F
Neuroscience; 2016 Dec; 338():160-182. PubMed ID: 27346146
[TBL] [Abstract][Full Text] [Related]
16. Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling.
Hervera A; Negrete R; Leánez S; Martín-Campos JM; Pol O
Mol Pain; 2011 Apr; 7():25. PubMed ID: 21486477
[TBL] [Abstract][Full Text] [Related]
17. Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.
Weibel R; Reiss D; Karchewski L; Gardon O; Matifas A; Filliol D; Becker JA; Wood JN; Kieffer BL; Gaveriaux-Ruff C
PLoS One; 2013; 8(9):e74706. PubMed ID: 24069332
[TBL] [Abstract][Full Text] [Related]
18. Congenic C57BL/6 mu opiate receptor (MOR) knockout mice: baseline and opiate effects.
Hall FS; Li XF; Goeb M; Roff S; Hoggatt H; Sora I; Uhl GR
Genes Brain Behav; 2003 Apr; 2(2):114-21. PubMed ID: 12884968
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
